Using advanced CT scans to better predict lung fibrosis progression

This study is testing whether advanced CT scans of the lungs — combined with blood tests and other measurements — can better predict how idiopathic pulmonary fibrosis (IPF) will progress in each patient. Right now, doctors use a simple breathing test to monitor the disease, but it doesn't catch subtle changes. The researchers hope that detailed computer analysis of lung scans, along with blood markers, will give a clearer picture of disease activity and how well treatments are working.

IPF is a serious lung disease that causes scarring, and despite two available medications, it remains life-threatening. The current standard breathing test is limited and doesn't detect early changes well. This study exists to find better tools for predicting which patients will decline faster and for measuring whether new treatments are actually helping.